MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
APPLICATION REVIEW SUBCOMMITTEE, GOVERNANCE SUBCOMMITTEE, AND
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH, TREATMENTS, AND CURES INITIATIVE OF 2020
Date: June 25, 2026
Time: 9:00 am to 5:00 pm*
Location: Hyatt Regency San Francisco Airport, Cypress Room BC
1333 Old Bayshore Hwy
Burlingame, CA 94010
Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below.
|
To view/listen: |
Go to https://www.youtube.com/cirmtv |
|
To listen or to remotely participate in oral public comment: |
Dial (669) 900-6833, or dial the toll free (833) 548-0282 Enter meeting ID 893 2202 5104 Press # twice See additional public comment instructions below. |
Public Comment Instructions
Written comment may be sent to the following email address: lmoralez@cirm.ca.gov. Please note that letters received less than 48 hours before the meeting may not be distributed until after the meeting.
Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location with the same limitations as those imposed on any other member of the public.
Members of the public who are listening to the meeting via teleconference and wish to make oral comment will have the opportunity to do so by doing the following:
- Once we have called for public comment, press *9, which will place you in a queue to make your comment.
- Once we call on you, you may have up to 3 minutes (specific time dependent on the number of members of the public wishing to speak) to make your public comment; please remember to be respectful of the time limit.
Open Session
- Call to Order
- Roll Call
- Chair’s Report
- Vice-Chair’s Report
- President’s Report
Consent Calendar
- Consideration of Minutes from the March 26, 2026, ICOC/ARS Meeting
- Consideration of Appointments/Reappointments of Scientific Members to the Grants Working Group
- Consideration of Amendments to the Preclinical Development and Rare Disease Acceleration Platform and Innovation and Delivery Eligibility Criteria
- Consideration of Award Management Policy Revisions
- Consideration of Requests to Attend Remotely (Gov’t Code Section 11123.2(j))
Open Session
- Consideration of Applications Submitted in Response to a Preclinical Development Program Announcements (PDEV)
- Consideration of Applications Submitted in Response to a Clinical Program Announcements (CLIN2)
Closed Session
- Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda items 11 and 12 above. (Health & Safety Code 125290.30(f) (3) (B) and (C)).
Open Session
- Closer to Cures
- Resolution Honoring Beth Drain
- Consideration of the Data Science and Software Engineering Concept Plan (INFR9)
- Update Regarding the Patient Perspective Score in Reviews
- Consideration of the FY ’26-’27 Research Budget
- Consideration of the FY ’26-’27 Administrative Budget
- Consideration of a Contract
- Update from Communications
- General Comments on the ARS Process
- Public Comment
- Adjournment
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
**NOTICE**
The California Institute for Regenerative Medicine and its Independent Citizens’ Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Claudette Mandac at the California Institute for Regenerative Medicine at 510-340-9101 or cmandac@cirm.ca.gov no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizens’ Oversight Committee meeting may be referred to Claudette Mandac at the California Institute for Regenerative Medicine at cmandac@cirm.ca.gov.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov/.
The Committee may take action on any item listed on this agenda.
*The duration of the meeting is an estimate, only. The meeting may continue beyond this estimated time in order to address the items on this agenda.